Abstract
Ketamine, a drug with rapid antidepressant effects and well-described effects on slow wave sleep (SWS), is a useful intervention for investigating sleep–wake mechanisms involved in novel therapeutics. The drug rapidly (within minutes to hours) reduces depressive symptoms in individuals with major depressive disorder (MDD) or bipolar disorder (BD), including those with treatment-resistant depression. Ketamine treatment elevates extracellular glutamate in the prefrontal cortex. Glutamate, in turn, plays a critical role as a proximal element in a ketamine-initiated molecular cascade that increases synaptic strength and plasticity, which ultimately results in rapidly improved mood. In MDD, rapid antidepressant response to ketamine is related to decreased waking as well as increased total sleep, SWS, slow wave activity (SWA), and rapid eye movement (REM) sleep. Ketamine also increases brain-derived neurotrophic factor (BDNF) levels. In individuals with MDD, clinical response to ketamine is predicted by low baseline delta sleep ratio, a measure of deficient early night production of SWS. Notably, there are important differences between MDD and BD that may be related to the effects of diagnosis or of mood stabilizers. Consistent with its effects on clock-associated molecules, ketamine alters the timing and amplitude of circadian activity patterns in rapid responders versus non-responders with MDD, suggesting that it affects mood-dependent central neural circuits. Molecular interactions between sleep homeostasis and clock genes may mediate the rapid and durable elements of clinical response to ketamine and its active metabolite.
References
Aeschbach D, Cutler AJ, Ronda JM (2008) A role for non-rapid-eye-movement sleep homeostasis in perceptual learning. J Neurosci 28(11):2766–2772
Agargun MY, Cartwright R (2003) REM sleep, dream variables and suicidality in depressed patients. Psychiatry Res 119(1–2):33–39
Antonijevic IA (2006) Depressive disorders – is it time to endorse different pathophysiologies? Psychoneuroendocrinology 31:1–15
Archer SN, Laing EE, Moller-Levet CS, van der Veen DR, Bucca G, Lazar AS, Santhi N, Slak A, Kabiljo R, von Schantz M, Smith CP, Dijk DJ (2014) Mistimed sleep disrupts circadian regulation of the human transcriptome. Proc Natl Acad Sci U S A 111(6):E682–E691
Bachmann V, Klein C, Bodenmann S, Schafer N, Berger W, Brugger P, Landolt HP (2012) The BDNF Val66Met polymorphism modulates sleep intensity: EEG frequency- and state-specificity. Sleep 35(3):335–344
Bagley J, Moghaddam B (1997) Temporal dynamics of glutamate efflux in the prefrontal cortex and in the hippocampus following repeated stress: effects of pretreatment with saline or diazepam. Neuroscience 77(1):65–73
Ballard ED, Ionescu DF, Vande Voort JL, Niciu MJ, Richards EM, Luckenbaugh DA, Brutsche NE, Ameli R, Furey ML, Zarate CA Jr (2014) Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. J Psychiatr Res 58:161–166
Ballard ED, Lally N, Nugent AC, Furey ML, Luckenbaugh DA, Zarate CA Jr (2015) Neural correlates of suicidal ideation and its reduction in depression. Int J Neuropsychopharmacol 18(1)
Ballard ED, Vande Voort JL, Bernert RA, Luckenbaugh DA, Richards EM, Niciu MJ, Furey ML, Duncan WC, Zarate CA Jr (2016) Nocturnal wakefulness is associated with next-day suicidal ideation in major depressive disorder and bipolar disorder. J Clin Psychiatry 77(7):825–831
Barbini B, Benedetti F, Colombo C, Dotoli D, Bernasconi A, Cigala-Fulgosi M, Florita M, Smeraldi E (2005) Dark therapy for mania: a pilot study. Bipolar Disord 7(1):98–101
Beck J, Hemmeter U, Brand S, Muheim F, Hatzinger M, Holsboer-Trachsler E (2010) Modafinil reduces microsleep during partial sleep deprivation in depressed patients. J Psychiatr Res 44(13):853–864
Bellet MM, Vawter MP, Bunney BG, Bunney WE, Sassone-Corsi P (2011) Ketamine influences CLOCK:BMAL1 function leading to altered circadian gene expression. PLoS One 6(8):e23982
Benca RM, Obermeyer WH, Thisted RA, Gillin JC (1992) Sleep and psychiatric-disorders – a metaanalysis. Arch Gen Psychiatry 49(8):651–668
Benedetti F, Colombo C (2011) Sleep deprivation in mood disorders. Neuropsychobiology 64(3):141–151
Benedetti F, Colombo C, Barbini B, Campori E, Smeraldi E (1999) Ongoing lithium treatment prevents relapse after total sleep deprivation. J Clin Psychopharmacol 19(3):240–245
Benedetti F, Barbini B, Campori E, Fulgosi MC, Pontiggia A, Colombo C (2001) Sleep phase advance and lithium to sustain the antidepressant effect of total sleep deprivation in bipolar depression: new findings supporting the internal coincidence model? J Psychiatr Res 35(6):323–329
Benedetti F, Barbini B, Colombo C, Smeraldi E (2007a) Chronotherapeutics in a psychiatric ward. Sleep Med Rev 11(6):509–522
Benedetti F, Dallaspezia S, Fulgosi MC, Barbini B, Colombo C, Smeraldi E (2007b) Phase advance is an actimetric correlate of antidepressant response to sleep deprivation and light therapy in bipolar depression. Chronobiol Int 24(5):921–937
Benedetti F, Calabrese G, Bernasconi A, Cadioli M, Colombo C, Dallaspezia S, Falini A, Radaelli D, Scotti G, Smeraldi E (2009) Spectroscopic correlates of antidepressant response to sleep deprivation and light therapy: a 3.0 Tesla study of bipolar depression. Psychiatry Res 173(3):238–242
Benedetti F, Dallaspezia S, Lorenzi C, Pirovano A, Radaelli D, Locatelli C, Poletti S, Colombo C, Smeraldi E (2012) Gene-gene interaction of glycogen synthase kinase 3-beta and serotonin transporter on human antidepressant response to sleep deprivation. J Affect Disord 136(3):514–519
Benedetti F, Riccaboni R, Locatelli C, Poletti S, Dallaspezia S, Colombo C (2014) Rapid treatment response of suicidal symptoms to lithium, sleep deprivation, and light therapy (chronotherapeutics) in drug-resistant bipolar depression. J Clin Psychiatry 75(2):133–140
Berger M, Vollmann J, Hohagen F, Konig A, Lohner H, Voderholzer U, Riemann D (1997) Sleep deprivation combined with consecutive sleep phase advance as a fast-acting therapy in depression: an open pilot trial in medicated and unmedicated patients. Am J Psychiatry 154(6):870–872
Bernert RA, Turvey CL, Conwell Y, Joiner TE Jr (2014) Association of poor subjective sleep quality with risk for death by suicide during a 10-year period: a longitudinal, population-based study of late life. JAMA Psychiat 71(10):1129–1137
Borbély A (1982) Two process model of sleep regulation. Hum Neurobiol 1:195–204
Borbély AA (1987) The S-deficiency hypothesis of depression and the two-process model of sleep regulation. Pharmacopsychiatry 20(1):23–29
Borbély AA, Wirz-Justice A (1982) Sleep, sleep deprivation and depression. A hypothesis derived from a model of sleep regulation. Hum Neurobiol 1(3):205–210
Breitstein J, Penix B, Roth BJ, Baxter T, Mysliwiec V (2014) Intensive sleep deprivation and cognitive behavioral therapy for pharmacotherapy refractory insomnia in a hospitalized patient. J Clin Sleep Med 10(6):689–690
Bunney BG, Bunney WE (2012) Rapid-acting antidepressant strategies: mechanisms of action. Int J Neuropsychopharmacol 15(5):695–713
Bunney BG, Bunney WE (2013) Mechanisms of rapid antidepressant effects of sleep deprivation therapy: clock genes and circadian rhythms. Biol Psychiatry 73(12):1164–1171
Campbell IG, Feinberg I (1996) NREM delta stimulation following MK-801 is a response of sleep systems. J Neurophysiol 76(6):3714–3720
Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, Hempstead BL, Lee FS (2004) Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 24(18):4401–4411
Clow A, Law R, Evans P, Vallence AM, Hodyl NA, Goldsworthy MR, Rothwell JR, Ridding MC (2014) Day differences in the cortisol awakening response predict day differences in synaptic plasticity in the brain. Stress 17(3):219–223
Cohen DA, Freitas C, Tormos JM, Oberman L, Eldaief M, Pascual-Leone A (2010) Enhancing plasticity through repeated rTMS sessions: the benefits of a night of sleep. Clin Neurophysiol 121(12):2159–2164
Cohrs S, Tergau F, Riech S, Kastner S, Paulus W, Ziemann U, Ruther E, Hajak G (1998) High-frequency repetitive transcranial magnetic stimulation delays rapid eye movement sleep. Neuroreport 9(15):3439–3443
Cornwell BR, Salvadore G, Furey M, Marquardt CA, Brutsche NE, Grillon C, Zarate CA Jr (2012) Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression. Biol Psychiatry 72(7):555–561
Cuesta M, Clesse D, Pevet P, Challet E (2009) New light on the serotonergic paradox in the rat circadian system. J Neurochem 110(1):231–243
Dallaspezia S, Benedetti F (2011) Chronobiological therapy for mood disorders. Expert Rev Neurother 11(7):961–970
Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, Kammerer WA, Quezado Z, Luckenbaugh DA, Salvadore G, Machado-Vieira R, Manji HK, Zarate CA Jr (2010a) A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67(8):793–802
DiazGranados N, Ibrahim LA, Brutsche NE, Ameli R, Henter ID, Luckenbaugh DA, Machado-Vieira R, Zarate CA Jr (2010b) Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry 71(12):1605–1611
Dijk D-J, Czeisler CA (1995) Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans. J Neurosci 15:3526–3538
Duman RS, Aghajanian GK (2012) Synaptic dysfunction in depression: potential therapeutic targets. Science 338(6103):68–72
Duncan WC (2009) Non-pharmacological treatments and chronobiological aspects of bipolar disorder: implications for novel therapeutics. In: Zarate C, Manji H (ed) Bipolar depression: molecular neurobiology, clinical diagnosis and pharmacology. Birkhauser, Switzerland, pp 95–116
Duncan WC Jr, Zarate CA Jr (2013) Ketamine, sleep, and depression: current status and new questions. Curr Psychiatry Rep 15(9):394
Duncan WC Jr, Pettigrew KD, Gillin JC (1979) REM architecture changes in bipolar and unipolar depression. Am J Psychiatry 136(11):1424–1427
Duncan WC Jr, Selter J, Brutsche N, Sarasso S, Zarate CA Jr (2013a) Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder. J Affect Disord 145(1):115–119
Duncan WC, Sarasso S, Ferrarelli F, Selter J, Riedner BA, Hejazi NS, Yuan P, Brutsche N, Manji HK, Tononi G, Zarate CA (2013b) Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder. Int J Neuropsychopharmacol 16(2):301–311
Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112(2):257–269
Eichhammer P, Kharraz A, Wiegand R, Langguth B, Frick U, Aigner JM, Hajak G (2002) Sleep deprivation in depression stabilizing antidepressant effects by repetitive transcranial magnetic stimulation. Life Sci 70(15):1741–1749
Eidelman P, Talbot LS, Gruber J, Hairston I, Harvey AG (2010) Sleep architecture as correlate and predictor of symptoms and impairment in inter-episode bipolar disorder: taking on the challenge of medication effects. J Sleep Res 19(4):516–524
Esser SK, Hill SL, Tononi G (2007) Sleep homeostasis and cortical synchronization: I. Modeling the effects of synaptic strength on sleep slow waves. Sleep 30(12):1617–1630
Even C, Thuile J, Santos J, Bourgin P (2005) Modafinil as an adjunctive treatment to sleep deprivation in depression. J Psychiatry Neurosci 30(6):432–433
Faraguna U, Vyazovskiy VV, Nelson AB, Tononi G, Cirelli C (2008) A causal role for brain-derived neurotrophic factor in the homeostatic regulation of sleep. J Neurosci 28(15):4088–4095
Feinberg I, Campbell IG (1993) Ketamine administration during waking increases delta EEG intensity in rat sleep. Neuropsychopharmacology 9:41–48
Franken P (2013) A role for clock genes in sleep homeostasis. Curr Opin Neurobiol 23(5):864–872
Franken P, Dijk DJ (2009) Circadian clock genes and sleep homeostasis. Eur J Neurosci 29(9):1820–1829
Frey S, Birchler-Pedross A, Hofstetter M, Brunner P, Gotz T, Munch M, Blatter K, Knoblauch V, Wirz-Justice A, Cajochen C (2012) Young women with major depression live on higher homeostatic sleep pressure than healthy controls. Chronobiol Int 29:278–294
Giese M, Beck J, Brand S, Muheim F, Hemmeter U, Hatzinger M, Holsboer-Trachsler E, Eckert A (2014) Fast BDNF serum level increase and diurnal BDNF oscillations are associated with therapeutic response after partial sleep deprivation. J Psychiatr Res 59:1–7
Gillin JC, Duncan W, Pettigrew KD, Frankel BL, Snyder F (1979) Successful separation of depressed, normal, and insomniac subjects by EEG sleep data. Arch Gen Psychiatry 36(1):85–90
Gorgulu Y, Caliyurt O (2009) Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression. Brain Res Bull 80(3):158–162
Gould TD, Manji HK (2002) The Wnt signaling pathway in bipolar disorder. Neuroscientist 8(5):497–511
Gould TD, Manji HK (2005) Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30(7):1223–1237
Gunnell D, Chang SS, Tsai MK, Tsao CK, Wen CP (2013) Sleep and suicide: an analysis of a cohort of 394,000 Taiwanese adults. Soc Psychiatry Psychiatr Epidemiol 48(9):1457–1465
Haile CN, Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Foulkes A, Iqbal S, Mahoney JJ 3rd, De La Garza R 2nd, Charney DS, Newton TF, Mathew SJ (2014) Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol 17(2):331–336
Hefti K, Holst SC, Sovago J, Bachmann V, Buck A, Ametamey SM, Scheidegger M, Berthold T, Gomez-Mancilla B, Seifritz E, Landolt HP (2013) Increased metabotropic glutamate receptor subtype 5 availability in human brain after one night without sleep. Biol Psychiatry 73(2):161–168
Hemmeter U, Hatzinger M, Brand S, Holsboer-Trachsler E (2007) Effect of flumazenil-augmentation on microsleep and mood in depressed patients during partial sleep deprivation. J Psychiatr Res 41(10):876–884
Hemmeter UM, Hemmeter-Spernal J, Krieg JC (2010) Sleep deprivation in depression. Expert Rev Neurother 10(7):1101–1115
Hiltunen L, Suominen K, Lonnqvist J, Partonen T (2011) Relationship between daylength and suicide in Finland. J Circadian Rhythms 9:10
Homayoun H, Moghaddam B (2007) NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 27(43):11496–11500
Huber R, Ghilardi MF, Massimini M, Tononi G (2004) Local sleep and learning. Nature 430(6995):78–81
Huber R, Ghilardi MF, Massimini M, Ferrarelli F, Riedner BA, Peterson MJ, Tononi G (2006) Arm immobilization causes cortical plastic changes and locally decreases sleep slow wave activity. Nat Neurosci 9:1169–1176
Huber R, Tononi G, Cirelli C (2007) Exploratory behavior, cortical BDNF expression, and sleep homeostasis. Sleep 30(2):129–139
Huber R, Maki H, Rosanova M, Casarotto S, Canali P, Casali AG, Tononi G, Massimini M (2013) Human cortical excitability increases with time awake. Cereb Cortex 23(2):332–338
Ibrahim L, Duncan WC, Luckenbaugh DA, Yuan P, Machado-Vieira R, Zarate CAJ (2011) Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study. Brain Res Bull 86:129–133
Ionescu DF, Luckenbaugh DA, Niciu MJ, Richards EM, Zarate CA Jr (2015) A single infusion of ketamine improves depression scores in patients with anxious bipolar depression. Bipolar Disord 17:438–443
JC W, Kelsoe JR, Schachat C, Bunney BG, DeModena A, Golshan S, Gillin JC, Potkin SG, Bunney WE (2009) Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biol Psychiatry 66(3):298–301
Kasper S, Hamon M (2009) Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action. World J Biol Psychiatry 10(2):117–126
Kasper S, Hajak G, Wulff K, Hoogendijk WJ, Montejo AL, Smeraldi E, Rybakowski JK, Quera-Salva MA, Wirz-Justice AM, Picarel-Blanchot F, Bayle FJ (2010) Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. J Clin Psychiatry 71(2):109–120
Kreuzer PM, Langguth B, Schecklmann M, Eichhammer P, Hajak G, Landgrebe M (2012) Can repetitive transcranial magnetic stimulation prolong the antidepressant effects of sleep deprivation? Brain Stimul 5(2):141–147
Kuhn M, Wolf E, Maier JG, Mainberger F, Feige B, Schmid H, Burklin J, Maywald S, Mall V, Jung NH, Reis J, Spiegelhalder K, Kloppel S, Sterr A, Eckert A, Riemann D, Normann C, Nissen C (2016) Sleep recalibrates homeostatic and associative synaptic plasticity in the human cortex. Nat Commun 7:12455
Kupfer DJ, Ehlers CL (1989) Two roads to rapid eye movement latency. Arch Gen Psychiatry 46(10):945–948
Kupfer DJ, Ulrich RF, Coble PA, Jarrett DB, Grochocinski VJ, Doman J, Matthews G, Borbély AA (1985) Electroencephalographic sleep of younger depressives. Comparison with normals. Arch Gen Psychiatry 42(8):806–810
Laje G, Lally N, Mathews D, Brutsche N, Chemerinski A, Akula N, Kelmendi B, Simen A, McMahon FJ, Sanacora G, Zarate C Jr (2012) Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients. Biol Psychiatry 72(11):e27–e28
Lam RW, Kennedy SH (2015) STAR*D and measurement-based care for depression: don’t toss out the baby. Can J Psychiatry 60(1):6–8
Lenox RH, Gould TD, Manji HK (2002) Endophenotypes in bipolar disorder. Am J Med Genet 114(4):391–406
Lewy AJ, Emens JS, Sack RL, Hasler BP, Bernert RA (2002) Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period. Chronobiol Int 19(3):649–658
Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329(5994):959–964
Li SX, Liu LJ, LZ X, Gao L, Wang XF, Zhang JT, Lu L (2013) Diurnal alterations in circadian genes and peptides in major depressive disorder before and after escitalopram treatment. Psychoneuroendocrinology 38(11):2789–2799
Linkowski P, Kerkhofs M, Rielaert C, Mendlewicz J (1986) Sleep during mania in manic-depressive males. Eur Arch Psychiatry Neurol Sci 235(6):339–341
Machado-Vieira R, Baumann J, Wheeler-Castillo C, Latov D, Henter ID, Salvadore G, Zarate CA (2010) The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments. Pharmaceuticals (Basel) 3:19–41
Maeng S, Zarate CA Jr (2007) The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep 9(6):467–474
McCarthy MJ, Nievergelt CM, Kelsoe JR, Welsh DK (2012) A survey of genomic studies supports association of circadian clock genes with bipolar disorder spectrum illnesses and lithium response. PLoS One 7(2):e32091
Murck H, Schubert MI, Schmid D, Schussler P, Steiger A, Auer DP (2009) The glutamatergic system and its relation to the clinical effect of therapeutic-sleep deprivation in depression – an MR spectroscopy study. J Psychiatr Res 43(3):175–180
Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, Aan Het Rot M, Collins KA, Mathew SJ, Charney DS, Iosifescu DV (2013) Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry 74:250–256
Murrough JW, Soleimani L, DeWilde KE, Collins KA, Lapidus KA, Iacoviello BM, Lener M, Kautz M, Kim J, Stern JB, Price RB, Perez AM, Brallier JW, Rodriguez GJ, Goodman WK, Iosifescu DV, Charney DS (2015) Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Psychol Med 45(16):3571–3580
Perlis ML, Grandner MA, Brown GK, Basner M, Chakravorty S, Morales KH, Gehrman PR, Chaudhary NS, Thase ME, Dinges DF (2016) Nocturnal wakefulness as a previously unrecognized risk factor for suicide. J Clin Psychiatry 77(6):726–733
Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18(23):9996–10015
Pigeon WR, Pinquart M, Conner K (2012) Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. J Clin Psychiatry 73(9):e1160–e1167
Pillai V, Kalmbach DA, Ciesla JA (2011) A meta-analysis of electroencephalographic sleep in depression: evidence for genetic biomarkers. Biol Psychiatry 70(10):912–919
Posternak MA, Zimmerman M (2005) Is there a delay in the antidepressant effect? A meta-analysis. J Clin Psychiatry 66(2):148–158
Price RB, Nock MK, Charney DS, Mathew SJ (2009) Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry 66(5):522–526
Price RB, Iosifescu DV, Murrough JW, Chang LC, Al Jurdi RK, Iqbal SZ, Soleimani L, Charney DS, Foulkes AL, Mathew SJ (2014) Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Depress Anxiety 31(4):335–343
Quitkin FM, Rabkin JG, Stewart JW, McGrath PJ, Harrison W, Davies M, Goetz R, Puig-Antich J (1985) Sleep of atypical depressives. J Affect Disord 8:61–67
Roecklein KA, Rohan KJ, Duncan WC, Rollag MD, Rosenthal NE, Lipsky RH, Provencio I (2009) A missense variant (P10L) of the melanopsin (OPN4) gene in seasonal affective disorder. J Affect Disord 114:279–285
Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163(11):1905–1917
Sabo E, Reynolds CF 3rd, Kupfer DJ, Berman SR (1991) Sleep, depression, and suicide. Psychiatry Res 36(3):265–277
Saeki T, Nakamura M, Hirai N, Noda Y, Hayasaka S, Iwanari H, Hirayasu Y (2013) Localized potentiation of sleep slow-wave activity induced by prefrontal repetitive transcranial magnetic stimulation in patients with a major depressive episode. Brain Stimul 6(3):390–396
Sahlem GL, Kalivas B, Fox JB, Lamb K, Roper A, Williams EN, Williams NR, Korte JE, Zuschlag ZD, El Sabbagh S, Guille C, Barth KS, Uhde TW, George MS, Short EB (2014) Adjunctive triple chronotherapy (combined total sleep deprivation, sleep phase advance, and bright light therapy) rapidly improves mood and suicidality in suicidal depressed inpatients: an open label pilot study. J Psychiatr Res 59:101–107
Sakurai T (2007) The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 8(3):171–181
Tononi G, Cirelli C (2006) Sleep function and synaptic homeostasis. Sleep Med Rev 10(1):49–62
Uz T (2005) Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum. Neuroscience 134:1309–1316
Vande Voort JL, Ballard ED, Luckenbaugh DA, Bernert RA, Richards EM, Niciu MJ, Park L, Machado-Vieira R, Duncan WC, Zarate CA (2016) Antisuicidal response following ketamine infusion is associated with decreased nighttime wakefulness in major depressive disorder and bipolar disorder. J Clin Psychiatry. Doi: 10.4088/JCP.15m10440. [Epub ahead of print]
Verkes RJ, Kerkhof GA, Beld E, Hengeveld MW, van Kempen GM (1996) Suicidality, circadian activity rhythms and platelet serotonergic measures in patients with recurrent suicidal behaviour. Acta Psychiatr Scand 93(1):27–34
Vyazovskiy VV, Riedner BA, Cirelli C, Tononi G (2007) Sleep homeostasis and cortical synchronization: II. A local field potential study of sleep slow waves in the rat. Sleep 30(12):1631–1642
Wehr TA, Goodwin FK (eds) (1983) Circadian rhythms in psychiatry. Psychobiology and psychopathology, vol 2. Boxwood Press, New York, NY
Wehr TA, Turner EH, Shimada JM, Lowe CH, Barker C, Leibenluft E (1998) Treatment of a rapidly cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleeo. Biol Psychiatry 43:822–828
Wiegand M, Berger M, Zulley J, von Zerssen D (1986) The effect of trimipramine on sleep in patients with major depressive disorder. Pharmacopsychiatry 19:198–199
Wiegand M, Berger M, Zulley J, Lauer C, von Zerssen D (1987) The influence of daytime naps on the therapeutic effect of sleep deprivation. Biol Psychiatry 22(3):389–392
Wiegand M, Riemann D, Schreiber W, Lauer CJ, Berger M (1993) Effect of morning and afternoon naps on mood after total sleep deprivation in patients with major depression. Biol Psychiatry 33:467–476
Willie JT, Chemelli RM, Sinton CM, Yanagisawa M (2001) To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 24:429–458
Wirz-Justice A, Terman M (2012) Chronotherapeutics (light and wake therapy) as a class of interventions for affective disorders. Handb Clin Neurol 106:697–713
Wirz-Justice A, Van den Hoofdakker RH (1999) Sleep deprivation in depression: what do we know, where do we go? Biol Psychiatry 46(4):445–453
Wirz-Justice A, Quinto C, Cajochen C, Werth E, Hock C (1999) A rapid-cycling bipolar patient treated with long nights, bedrest and light. Biol Psychiatry 45:1075–1077
Wright RA, Johnson BG, Zhang C, Salhoff C, Kingston AE, Calligaro DO, Monn JA, Schoepp DD, Marek GJ (2013) CNS distribution of metabotropic glutamate 2 and 3 receptors: transgenic mice and [(3)H]LY459477 autoradiography. Neuropharmacology 66:89–98
Wu JC, Kelsoe JR, Schachat C, Bunney BG, DeModena A, Golshan S, Gillin JC, Potkin SG, Bunney WE (2009) Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biol Psychiatry 66 (3):298–301
Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, Alkondon M, Yuan P, Pribut HJ, Singh NS, Dossou KS, Fang Y, Huang XP, Mayo CL, Wainer IW, Albuquerque EX, Thompson SM, Thomas CJ, Zarate CA Jr, Gould TD (2016) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533(7604):481–486
Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63(8):856–864
Zarate CA Jr, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A, Selter J, Marquardt CA, Liberty V, Luckenbaugh DA (2012) Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 71(11):939–946
Zhao C, Eisinger BE, Driessen TM, Gammie SC (2014) Addiction and reward-related genes show altered expression in the postpartum nucleus accumbens. Front Behav Neurosci 8:388
Acknowledgements
The authors thank the 7SE research unit and staff for their support. Ioline Henter (NIMH) provided invaluable editorial assistance.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Duncan, W.C., Ballard, E.D., Zarate, C.A. (2017). Ketamine-Induced Glutamatergic Mechanisms of Sleep and Wakefulness: Insights for Developing Novel Treatments for Disturbed Sleep and Mood. In: Landolt, HP., Dijk, DJ. (eds) Sleep-Wake Neurobiology and Pharmacology . Handbook of Experimental Pharmacology, vol 253. Springer, Cham. https://doi.org/10.1007/164_2017_51
Download citation
DOI: https://doi.org/10.1007/164_2017_51
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11270-7
Online ISBN: 978-3-030-11272-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)